BTI
BIIB icon

Blue Trust Inc’s Biogen BIIB Stock Holding History

Blue Trust Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Sell
507
-53
-9% -$10.1K ﹤0.01% 1002
2026
Q1 		$103K Sell
560
-280
-33% -$51.6K ﹤0.01% 1014
2025
Q4 		$148K Sell
840
-362
-30% -$59.1K ﹤0.01% 892
2025
Q3 		$168K Buy
1,202
+95
+9% +$12.8K ﹤0.01% 868
2025
Q2 		$139K Buy
1,107
+522
+89% +$65K ﹤0.01% 904
2025
Q1 		$80.1K Buy
585
+11
+2% +$1.57K ﹤0.01% 1099
2024
Q4 		$87.8K Buy
574
+102
+22% +$17.2K ﹤0.01% 986
2024
Q3 		$109K Buy
472
+294
+165% +$61.5K ﹤0.01% 1173
2024
Q2 		$38.4K Buy
178
+127
+249% +$27.6K ﹤0.01% 1369
2024
Q1 		$11K Sell
51
-63
-55% -$14.8K ﹤0.01% 1416
2023
Q4 		$29K Sell
114
-24
-17% -$5.89K ﹤0.01% 1145
2023
Q3 		$40K Buy
138
+37
+37% +$9.9K ﹤0.01% 917
2023
Q2 		$28K Sell
101
-92
-48% -$27.4K ﹤0.01% 910
2023
Q1 		$54K Buy
193
+9
+5% +$2.49K ﹤0.01% 999
2022
Q4 		$49K Buy
184
+112
+156% +$31.6K ﹤0.01% 922
2022
Q3 		$15K Sell
72
-2
-3% -$425 ﹤0.01% 1192
2022
Q2 		$16K Buy
+74
New +$15.1K ﹤0.01% 1032

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blue Trust Inc's BIIB Position: Q2 2026 in Review

Blue Trust Inc reduced its Biogen (BIIB) stake by 9.5% in Q2 2026, selling an estimated $10.1K and leaving 507 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Blue Trust Inc first reported a position in BIIB in Q2 2022 and has held it in 17 quarters since. The position peaked at $168K in Q3 2025. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Blue Trust Inc held 507 shares of Biogen worth $110K as of Q2 2026.
  • Blue Trust Inc sold 53 Biogen shares in Q2 2026, an estimated $10.1K.
  • Biogen made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1002 holding.
  • Blue Trust Inc first reported a position in Biogen in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Biogen position peaked at $168K in Q3 2025.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.